icddr,b ends year 2020 with net surplus USD 667k : Annual Report 2020 published

icddr,b ends year 2020 with net surplus USD 667k : Annual Report 2020 published



Dhaka December 26 2021 :



icddr,b is an international health research institute based in Bangladesh.

Policymakers and practitioners utilise our evidence and expertise to improve health outcomes and prevent premature death and disability worldwide. Established more than 60 years ago, we continue to provide life-saving services to the people of Bangladesh, and to nurture the next generation of global health leaders. Our work has a substantial impact here in Bangladesh and globally. 

icddr,b’s 2020 Annual Report, which records another year of our achievements, and a commitment to improving the health of people in Bangladesh and in the Global South. 

According to Annual report 2020, icddr,b’s overall revenue for 2020 amounted to USD 64.78 million compared with a total expenditure of USD 64.11 million, generating a net surplus for the year of USD 667k.

It’s overall revenue for 2020 of USD 64.78m which represented a decrease of 5 percent amounting to USD 3.7m compared with 2019. Research grant income for 2020 reduced by 5 percent equal to USD 2.8 million vs. 2019, which is mainly due to the reduction of the project activities during the C19 pandemic.

Unrestricted lab income decreased by USD 560k.

Remembering the greatest scientific discoveries – Celebrating six decades of Bangladesh-based scientific research, which saves millions of lives globally.

icddr,b response to COVID-19 pandemic  which initiated more than 60 diverse research projects exclusively focused on COVID-19, ranging from strengthening and improving national health system, understanding the transmission dynamics of SARS-CoV-2, variant surveillance, therapeutic trials, impact on food security, economic loss and mental health.

Strengthening SDG guideline for neonatal mortality – icddr,b, and partners contributed to revising the World Health Organization’s Sustainable Development Goals target recommendations for newborn children.

Soapy water – icddr,b’s soapy water made it to the WHO’s interim guideline titled ‘Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19. Our scientists have also been working with the WHO on detailed handwashing guidelines to strengthen the prevention of COVID-19. 

Childhood malnutrition – It has demonstrated that certain bacteria residing in the upper small intestine of children are associated with inflammation and other changes that ultimately lead to stunted growth of children.

Health protection for the forcibly displaced – icddr,b continues to play a key role in protecting the health of forcibly displaced Myanmar nationals in Bangladesh through supporting cholera vaccine administration, disease surveillance, among many others.

Menstrual hygiene management – Highlighted innovations to promote better menstrual hygiene management.

High-quality clinical laboratory diagnostic service has carried out over 426,000 tests delivering an important service to icddr,b researchers, as well as patients who benefit from our affordable, expertise, and accredited laboratory tests and diagnostics.

Meanwhile, diarrhoeal disease hospitals in Dhaka and Matlab have provided life-saving, free clinical services to over 152,000 people in 2020. Additionally, along with UNICEF, we are operating a 200-bed Severe Acute Respiratory Infection Isolation and Treatment Centre in Teknaf, Cox’s Bazar to provide critical care, diagnosis, and oxygen therapy for COVID-19 patients from both Bangladeshi and Rohingya communities.

Details of these and other important research initiatives are highlighted in the Annual Report.

The organization trust the report provided with better insight into icddr,b’s most recent research, activities, and accomplishments with the potential for global impact in the future. 

icddr,b’s life-saving research is only possible due to the generosity of our collaborators, supporters, and donors.

Without them, icddr,b could not continue to generate affordable, easily scalable evidence and solutions that have huge potential to save lives in vulnerable low-income settings.